Schedule 13D ownership disclosure

AILERON THERAPEUTICS INC

Security class unavailable · CUSIP: 00887A105

Event date: 2020-03-17

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
1,882,119
Percent of class
6.7700%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-20-034979
Form type
SC 13D/A
Filer
Rein Therapeutics, Inc.
CIK
CIK 1420565
Filed
Mar 18, 2020
Reporting period
Mar 17, 2020
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub